Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 50, 2016 - Issue 4
Journal homepage
430
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)

Sophie D. FossåNational Advisory Unit on Late Effects after Cancer Treatment, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ;Cancer Registry of Norway, Oslo, Norway; ;Faculty of Medicine, University of Oslo, Oslo, Norway; Correspondence[email protected]
,
Anne Holck StoråsNational Advisory Unit on Late Effects after Cancer Treatment, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway;
,
Eivind A. SteinsvikDivision of Surgery, Department of Otorhinolaryngology, Akershus University Hospital, Lørenskog, Norway;
,
Tor Aa MyklebustCancer Registry of Norway, Oslo, Norway;
,
Lars M. EriFaculty of Medicine, University of Oslo, Oslo, Norway; ;Division of Urology, Oslo University Hospital, Oslo, Norway;
,
Jon H. LogeFaculty of Medicine, University of Oslo, Oslo, Norway; ;Regional Centre for Excellence in Palliative Care, Oslo University Hospital, Oslo, Norway
&
Alv A. DahlNational Advisory Unit on Late Effects after Cancer Treatment, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ;Faculty of Medicine, University of Oslo, Oslo, Norway;
show all
Pages 280-285 | Received 02 Dec 2015, Accepted 04 Mar 2016, Published online: 06 Apr 2016

References

  • Sonn GA, Sadetsky N, Presti JC, Litwin MS. Differing perceptions of quality of life in patients with prostate cancer and their doctors. J Urol 2009;182:2296–302.
  • Rnic K, Linden W, Tudor I, Pullmer R, Vodermaier A. Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments. Prostate Cancer Prostatic Dis 2013;16:111–22.
  • Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993;46:1417–32.
  • Szymanski KM, Wei JT, Dunn RL, Sanda MG. Development and validation of an abbreviated version of the Expanded Prostate Cancer Index Composite Instrument for measuring health-related quality of life among prostate cancer survivors. Urology 2010;76:1245–50.
  • Litwin MS, Hays R, Fink A, Ganz PA, Leake B, Brook R. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998;36:1002–12.
  • Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899–905.
  • Chung KJ, Kim JJ, Lim SH, Kim TH, Han DH, Lee SW. Development and validation of the Korean version of Expanded Prostate Cancer Index Composite: questionnaire assessing health-related quality of life after prostate cancer treatment. Korean J Urol 2010;51:601–12.
  • Alves E, Medina R, Andreoni C. Validation of the Brazilian version of the Expanded Prostate Cancer Index Composite (EPIC) for patients submitted to radical prostatectomy. Int Braz J Urol 2013;39:344–52.
  • Beyer B, Huland H, Feick G, Graefen M. Expanded Prostate Cancer Index Composite (EPIC-26). Results of functional treatment in patients with localized prostate cancer. Urologe A 2015;54:1591–5.
  • Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, et al. Does a surgeon`s annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study. Scand J Urol 2013;47:92–100.
  • Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int 2012;109:1366–74.
  • Barry MJ, Fowler FJ Jr, OLeary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol 1992;148:1549–57.
  • D'Amico AV, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, et al. Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease. J Clin Oncol 2009;27:3923–8.
  • Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, et al. Bother problems in prostate cancer patients after curative treatment. Urol Oncol 2013;31:1067–78.
  • Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, et al. A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up. Urology 2013;81:781–6.
  • Fayers PM, Machin D. Scores and Measurements: Validity, Reliability, Sensitivity. In: John Wiley & Sons, LTD, editors. Quality of Life, Assessment, Analysis and Interpretation. Chichester; 2000, Chapter 3, pp. 45–71.
  • Kline P. Test Construction. In: A Psychometrics Primer. Free Association Books. London; 2000, Chapter 4, pp. 46–68.
  • Kimura M, Bañez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, et al. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction. Andrology 2013;1:256–61.
  • Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–26.
  • Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol 2015;67:460–7.
  • Oslo University Hospital. [National Advisory Unit on Late Effects after Cancer Treatment]. Available from http://www.oslo-universitetssykehus.no/omoss_/avdelinger_/nasjonal-kompetansetjeneste-for-seneffekter-etter-kreftbehandling_

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.